Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Viatris Inc
(NQ:
VTRS
)
10.95
-0.12 (-1.13%)
Streaming Delayed Price
Updated: 2:15 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Viatris Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Recent Stock Purchase September 2022
September 19, 2022
I make a stock purchase every single month no matter what is going on in the world and despite the doom and gloom headlines.
Via
Talk Markets
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
On Monday, 429 stocks made new 52-week lows.
Via
Benzinga
Viatris: Q2 Earnings Insights
August 08, 2022
Viatris (NASDAQ:VTRS) reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Expert Ratings for Viatris
May 10, 2022
Analysts have provided the following ratings for Viatris (NASDAQ:VTRS) within the last quarter:
Via
Benzinga
7 Screaming Buy Stock Picks to Beat the September Market Slump
September 13, 2022
Savvy investors can use these stock picks to beat the market and take advantage of market weakness and panic selling.
Via
InvestorPlace
September 2022 Stock Considerations
September 08, 2022
Let’s take a look at my September stock considerations which are similar to recent considerations from one to four months ago.
Via
Talk Markets
Stocks That Hit 52-Week Lows On Thursday
September 01, 2022
On Thursday, 529 companies set new 52-week lows.
Via
Benzinga
Viatris Posts Q1 Profit Despite 5% Dip In Sales, Reiterates FY22 Guidance Above Consensus
May 09, 2022
Via
Benzinga
Recap: Viatris Q1 Earnings
May 09, 2022
Viatris (NASDAQ:VTRS) reported its Q1 earnings results on Monday, May 9, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
This Company Reports Its Consumer Therapeutics Could Be A Game Changer For People With Skin Problems
August 24, 2022
From allergies and insect bites to sunburns and irritations, the human skin can succumb to several conditions, including acne, psoriasis, blisters, hives, actinic keratosis, rosacea, and carbuncle.
Via
Benzinga
Recession Investing: 5 High Yield Dividend Stocks For A Downturn
August 03, 2022
As the healthcare industry absorbed enormous amounts of profits during the Covid-19 pandemic, many healthcare companies will be increasing shareholder distributions to entice investors to buy their...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
June 14, 2022
Upgrades
Via
Benzinga
Viatris' Mylan Recalls One Batch Of Insulin Glargine Due To Missing Label
April 13, 2022
Mylan Pharmaceuticals Inc, a Viatris Inc (NASDAQ: VTRS) company, is
Via
Benzinga
High Dividend 50: Viatris
March 25, 2022
Viatris is currently offering an above-average dividend yield of 4.4%. The company has posted GAAP losses in each of the last two years but its payout ratio is only 13% using adjusted EPS.
Via
Talk Markets
Earnings Scheduled For August 8, 2022
August 08, 2022
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.
Via
Benzinga
7 High-Quality Dividend Stocks With High Yields
June 07, 2022
These are the best dividend stocks with high yields to invest in now. BIP, EPR, FL, KMI, KHC, VTRS, and WBA can make great investments.
Via
InvestorPlace
Looking Into Viatris's Return On Capital Employed
June 03, 2022
According to Benzinga Pro, during Q1, Viatris (NASDAQ:VTRS) earned $399.20 million, a 251.33% increase from the preceding quarter. Viatris's sales decreased to $4.19 billion, a 3.45% change since Q4.
Via
Benzinga
Current Report: Viatris
May 20, 2022
Viatris Inc’s price per share was $11.68 as of yesterday's market close. One year ago its price was $15.59.
Via
Talk Markets
3 Top S&P 500 Stock Market Gainers Today
May 09, 2022
Hard-hit stocks led S&P 500 winners. Commodity stocks were the big losers.
Via
Investor's Business Daily
27 Recession-Resistant Stocks To Look At Now
May 09, 2022
When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2022
May 10, 2022
Upgrades
Via
Benzinga
Pfizer: What Comes After the Covid-19 Fire?
April 21, 2022
Success with Pfizer's Covid-19 vaccine maintains the PFE stock status as a dividend aristocrat, but don't expect miracles.
Via
InvestorPlace
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More
April 13, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal
Via
Benzinga
Earnings Scheduled For May 9, 2022
May 09, 2022
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Via
Benzinga
Biogen’s Aduhelm Crashes the Biotech Sector
April 13, 2022
Aduhelm's quick approval and high price have set off pushback on the whole FDA and Medicare drug process which is not good for BIIB stock.
Via
InvestorPlace
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...
Via
Benzinga
7 Cheap Stocks to Buy Now if You Have $100 to Spend
March 22, 2022
The S&P 500 is off to a forgettable start this year, but that creates multiple buying opportunities if you're looking for cheap stocks.
Via
InvestorPlace
35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill
March 17, 2022
Via
Benzinga
7 Drug Stocks to Consider After the Viatris Plunge
March 10, 2022
As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.
Via
InvestorPlace
AbbVie, Alvotech Resolve US Patent Dispute Related To Humira Biosimilar
March 09, 2022
Alvotech Holdings S.A. has entered into a settlement agreement with AbbVie Inc (NYSE: ABBV), allowing Alvotech to market AVT02 (100 mg/mL), its high-...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.